SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: JPetroInc, zoomboom
Search This Board: 
Last Post: 4/27/2017 12:33:05 PM - Followers: 691 - Board type: Free - Posts Today: 0

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.

 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.

ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in FacebookTwitter, LinkedIn & Google+
 
                                                                                       


 

NEWS



Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 

ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3
 
 
 

 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111

 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 

info@amarantus.com
pr@amarantus.com


Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
Gerald@amarantus.com



IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475

ir@amarantus.com


 

TRANSFER AGENT

VStock Transfer, LLC
Allison Niccols
77 Spruce Street
Suite 201
Cedarhurst, N 11516
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.VStockTransfer.com

 

 
 
                                                                            

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS
Current Price
Volume:
Bid Ask Day's Range
SureTrader
AMBS News: Current Report Filing (8-k) 04/17/2017 04:29:46 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 04/06/2017 09:03:57 AM
AMBS News: Current Report Filing (8-k) 03/28/2017 04:04:12 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 03/20/2017 12:13:42 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 03/06/2017 04:20:37 PM
PostSubject
#126255   unfortunately, this is and will remain "dead money" JPetroInc 04/27/17 12:33:04 PM
#126254   655 Montgomery St. Suite 900 in San Francisco JPetroInc 04/27/17 09:27:58 AM
#126253   do they even have a facility they need Inoviorulez 04/26/17 10:28:47 PM
#126252   end of month sell off JPetroInc 04/26/17 10:22:59 AM
#126251   just may see my name next to BCM JPetroInc 04/25/17 08:04:11 PM
#126250   Well if your goal is to inform, then Inoviorulez 04/25/17 06:47:41 PM
#126249   Even though it may be limited - they're JPetroInc 04/25/17 01:44:25 PM
#126248   The chart may look pretty good to you jugs 04/25/17 01:16:33 PM
#126247   AMBS management and their financial cohorts have to JPetroInc 04/25/17 11:27:18 AM
#126246   The chart looks pretty good. joboggi 04/25/17 10:41:25 AM
#126245   As we all should. I applaud you JP itwentdwnhwmch 04/23/17 09:34:32 PM
#126244   Keeping the unsuspecting informed JPetroInc 04/23/17 07:01:48 PM
#126242   what a complete & utter mess - huh Gerald? JPetroInc 04/22/17 02:44:28 PM
#126241   What's the commitment date when short a stock? myersvodka 04/21/17 12:45:49 PM
#126240   MM's trading amongst themselves - JPetroInc 04/20/17 10:27:54 AM
#126238   Gerald's karma will be a 'living nightmare' for JPetroInc 04/18/17 07:54:13 PM
#126237  Restored Gerald is a lying sack of shit. Peggy 04/18/17 12:49:07 PM
#126236   couldn't agree with you more JPetroInc 04/18/17 09:56:52 AM
#126235   JP, that's typical of many biotechs even with SidVicious 04/18/17 09:40:06 AM
#126234   ESS update - Gerald had no money to JPetroInc 04/18/17 09:02:33 AM
#126233   More interesting tid bits from the 8k- hnbadger1 04/18/17 07:55:19 AM
#126232   read SEC filings much? JPetroInc 04/17/17 09:43:14 PM
#126231   How do you know,if you do not mind sharing?. newflow 04/17/17 05:57:59 PM
#126230   Gerald gave 35% of ESS to the new JPetroInc 04/17/17 05:42:31 PM
#126229   With Sed's assets + AMBS assets with proper newflow 04/17/17 01:02:06 PM
#126228   Thanks have not been following AMBS but this Ragnaroc 04/17/17 12:59:12 PM
#126227   SeD's the real deal JPetroInc 04/17/17 12:39:50 PM
#126226   Is this a legitimate attempt or another scam Ragnaroc 04/17/17 11:04:37 AM
#126225   Amarantus Bioscience Holdings, Inc. (OTCPK: AMBS), a US-headquartered zoomboom 04/17/17 09:49:16 AM
#126224   Amarantus Forms Subsidiaries "Elto Pharma" to Focus on JPetroInc 04/17/17 09:46:56 AM
#126223   http://www.amarantus.com/news/press-releases/detail/2065/amarantus-forms-subsidi zoomboom 04/17/17 09:45:18 AM
#126222   yeah if you think the drop from $12 JPetroInc 04/13/17 02:12:24 PM
#126221   Good time to add or jump in. $AMBS jjr04001 04/13/17 11:19:42 AM
#126220   0.035 / 0.0477 JPetroInc 04/13/17 08:42:32 AM
#126218   http://www.zerohedge.com/news/2017-04-10/sec-cracks-down-fake-news-pump-and-dump sante1 04/13/17 04:29:00 AM
#126217   I see GC being a faint memory if joboggi 04/13/17 12:56:53 AM
#126216   the World hasn't stopped JPetroInc 04/12/17 12:38:11 PM
#126215   Did the world stop, the AMBS board has joboggi 04/12/17 03:38:19 AM
#126214   I don't get the warm fuzzies over SeD's JPetroInc 04/08/17 12:02:17 AM
#126213   if SeD pulls you'll be buying in the tripps JPetroInc 04/07/17 09:09:21 PM
#126212   Buy in the 3,s myersvodka 04/07/17 01:19:19 PM
#126211   Daily TA looking Fugly JPetroInc 04/06/17 07:21:15 PM
#126210   Quote:"Following SeD Biomedical's preliminary due diligence, SeD Biomedical newflow 04/06/17 03:42:49 PM
#126209   they all lie - starting with Gerald JPetroInc 04/06/17 03:01:23 PM
#126207   Dont have faith in the PR's released by newflow 04/06/17 12:05:39 PM
#126206   It seems that if there is not an dlausch 04/06/17 11:02:56 AM
#126205   All the PR is doing is letting shareholders SidVicious 04/06/17 10:23:59 AM
#126204   SAN FRANCISCO, April 5, 2017 /PRNewswire/ -- JPetroInc 04/06/17 10:15:05 AM
#126203   SeD got a whiff of just how slimy JPetroInc 04/06/17 10:11:40 AM
#126202   Extremely vague update. No specifics. leslunier 04/06/17 08:38:04 AM
PostSubject